Clinical Practice Guidelines for Hypophosphatasia.

enzyme replacement therapy guideline hypophosphatasia systematic review

Journal

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
ISSN: 0918-5739
Titre abrégé: Clin Pediatr Endocrinol
Pays: Japan
ID NLM: 9433330

Informations de publication

Date de publication:
2020
Historique:
received: 23 07 2019
accepted: 16 08 2019
entrez: 8 2 2020
pubmed: 8 2 2020
medline: 8 2 2020
Statut: ppublish

Résumé

Hypophosphatasia (HPP) is a rare bone disease caused by inactivating mutations in the

Identifiants

pubmed: 32029969
doi: 10.1297/cpe.29.9
pii: 2019-0022
pmc: PMC6958520
doi:

Types de publication

Journal Article

Langues

eng

Pagination

9-24

Informations de copyright

2020©The Japanese Society for Pediatric Endocrinology.

Références

Am J Med Genet A. 2017 Mar;173(3):601-610
pubmed: 28127875
J Pediatr. 1997 May;130(5):825-8
pubmed: 9152296
Osteoporos Int. 2015 Dec;26(12):2743-57
pubmed: 26245849
J Bone Miner Res. 2015 Sep;30(9):1726-37
pubmed: 25736332
J Bone Miner Res. 2009 Jun;24(6):1132-4
pubmed: 19113923
J Clin Endocrinol Metab. 1996 Dec;81(12):4458-61
pubmed: 8954059
Mol Genet Metab. 2014 Mar;111(3):404-407
pubmed: 24100244
J Bone Miner Res. 2011 Oct;26(10):2389-98
pubmed: 21713987
J Bone Miner Res. 2017 Apr;32(4):667-675
pubmed: 28084648
Eur J Hum Genet. 2014 Oct;22(10):1160-4
pubmed: 24569605
Eur J Pediatr. 2016 Mar;175(3):433-7
pubmed: 26459154
Orphanet J Rare Dis. 2009 Feb 21;4:6
pubmed: 19232125
Mol Genet Metab. 2011 Sep-Oct;104(1-2):48-60
pubmed: 21704546
Prenat Diagn. 2008 Nov;28(11):993-8
pubmed: 18925618
Orphanet J Rare Dis. 2007 Oct 04;2:40
pubmed: 17916236
N Engl J Med. 2012 Mar 8;366(10):904-13
pubmed: 22397652
J Clin Res Pediatr Endocrinol. 2012 Mar;4(1):34-8
pubmed: 22394703
J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S25-33
pubmed: 20049532
Osteoporos Int. 2017 Sep;28(9):2653-2662
pubmed: 28547134
Pediatr Radiol. 1991;21(6):421-7
pubmed: 1749675
J Bone Miner Res. 2012 May;27(5):987-94
pubmed: 22322541
Nat Rev Endocrinol. 2016 Apr;12(4):233-46
pubmed: 26893260
J Clin Periodontol. 1993 Oct;20(9):615-22
pubmed: 8227447
J Dent. 2010 Apr;38(4):296-306
pubmed: 20004698
Am J Med Genet A. 2015 Dec;167A(12):2869-92
pubmed: 26394607
Eur J Pediatr. 2005 May;164(5):277-82
pubmed: 15660230
J Bone Miner Res. 2009 Aug;24(8):1493-505
pubmed: 19335222
J Hum Genet. 2011 Mar;56(3):174-6
pubmed: 21307860
Arch Dis Child. 1990 Jan;65(1):130-1
pubmed: 2301976
Childs Nerv Syst. 2009 Feb;25(2):217-23
pubmed: 18769927
J Hum Genet. 2011 Feb;56(2):166-8
pubmed: 21179104
Clin Genet. 1999 Oct;56(4):313-7
pubmed: 10636450
JCI Insight. 2016 Jun 16;1(9):e85971
pubmed: 27699270
J Clin Endocrinol Metab. 2016 Jan;101(1):334-42
pubmed: 26529632
J Clin Endocrinol Metab. 2000 Feb;85(2):743-7
pubmed: 10690885
Best Pract Res Clin Rheumatol. 2008 Mar;22(1):113-27
pubmed: 18328985
Mol Genet Metab. 2017 Sep;122(1-2):4-17
pubmed: 28888853
Bone. 2015 Jun;75:229-39
pubmed: 25731960
BMC Musculoskelet Disord. 2016 Aug 09;17:332
pubmed: 27507156
Calcif Tissue Int. 2016 Apr;98(4):398-416
pubmed: 26590809
Int J Paediatr Dent. 2013 May;23(3):153-9
pubmed: 22672232
Clin Endocrinol (Oxf). 2017 Jul;87(1):10-19
pubmed: 28374482
Eur J Intern Med. 2016 Apr;29:40-5
pubmed: 26783040
Subcell Biochem. 2015;76:309-22
pubmed: 26219717
Bone. 2007 Jun;40(6):1655-61
pubmed: 17395561
J Clin Endocrinol Metab. 2013 Dec;98(12):4606-12
pubmed: 24064686
Bone. 2013 May;54(1):21-7
pubmed: 23352924
Bone. 2017 Sep;102:15-25
pubmed: 28238808

Auteurs

Toshimi Michigami (T)

Department of Bone and Mineral Research, Research Institute, Osaka Women's and Children's Hospital, Osaka Prefectural Hospital Organization, Osaka, Japan.
Task Force for Hypophosphatasia Guidelines.

Yasuhisa Ohata (Y)

Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Task Force for Hypophosphatasia Guidelines.

Makoto Fujiwara (M)

Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Task Force for Hypophosphatasia Guidelines.

Hiroshi Mochizuki (H)

Division of Endocrinology and Metabolism, Saitama Children's Medical Center, Saitama, Japan.
Task Force for Hypophosphatasia Guidelines.

Masanori Adachi (M)

Department of Endocrinology and Metabolism, Kanagawa Children's Medical Center, Kanagawa, Japan.
Task Force for Hypophosphatasia Guidelines.

Taichi Kitaoka (T)

Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Task Force for Hypophosphatasia Guidelines.

Takuo Kubota (T)

Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Task Force for Hypophosphatasia Guidelines.

Hideaki Sawai (H)

Department of Obstetrics and Gynecology, Hyogo College of Medicine, Hyogo, Japan.
Task Force for Hypophosphatasia Guidelines.

Noriyuki Namba (N)

Division of Pediatrics and Perinatology, Tottori University Faculty of Medicine, Tottori, Japan.
Task Force for Hypophosphatasia Guidelines.

Kosei Hasegawa (K)

Department of Pediatrics, Okayama University Hospital, Okayama, Japan.
Task Force for Hypophosphatasia Guidelines.

Ikuma Fujiwara (I)

Department of Pediatrics, Sendai City Hospital, Miyagi, Japan.
Task Force for Hypophosphatasia Guidelines.

Keiichi Ozono (K)

Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Task Force for Hypophosphatasia Guidelines.

Classifications MeSH